BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11857380)

  • 1. Expression of membrane type 1 matrix metalloproteinase (MT1-MMP) in A2058 melanoma cells is associated with MMP-2 activation and increased tumor growth and vascularization.
    Sounni NE; Baramova EN; Munaut C; Maquoi E; Frankenne F; Foidart JM; Noël A
    Int J Cancer; 2002 Mar; 98(1):23-8. PubMed ID: 11857380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of integrin alpha(v)beta(3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo.
    Hofmann UB; Westphal JR; Van Kraats AA; Ruiter DJ; Van Muijen GN
    Int J Cancer; 2000 Jul; 87(1):12-9. PubMed ID: 10861447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression.
    Sounni NE; Devy L; Hajitou A; Frankenne F; Munaut C; Gilles C; Deroanne C; Thompson EW; Foidart JM; Noel A
    FASEB J; 2002 Apr; 16(6):555-64. PubMed ID: 11919158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism.
    Monea S; Lehti K; Keski-Oja J; Mignatti P
    J Cell Physiol; 2002 Aug; 192(2):160-70. PubMed ID: 12115722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane type 1 matrix metalloproteinase-associated degradation of tissue inhibitor of metalloproteinase 2 in human tumor cell lines.
    Maquoi E; Frankenne F; Baramova E; Munaut C; Sounni NE; Remacle A; Noël A; Murphy G; Foidart JM
    J Biol Chem; 2000 Apr; 275(15):11368-78. PubMed ID: 10753951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasiveness of hepatocellular carcinoma cell lines: contribution of membrane-type 1 matrix metalloproteinase.
    Murakami K; Sakukawa R; Ikeda T; Matsuura T; Hasumura S; Nagamori S; Yamada Y; Saiki I
    Neoplasia; 1999 Nov; 1(5):424-30. PubMed ID: 10933057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity.
    Lunter PC; van Kilsdonk JW; van Beek H; Cornelissen IM; Bergers M; Willems PH; van Muijen GN; Swart GW
    Cancer Res; 2005 Oct; 65(19):8801-8. PubMed ID: 16204050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocyte membrane type 1-matrix metalloproteinase. Prostaglandin-dependent regulation and role in metalloproteinase-2 activation.
    Shankavaram UT; Lai WC; Netzel-Arnett S; Mangan PR; Ardans JA; Caterina N; Stetler-Stevenson WG; Birkedal-Hansen H; Wahl LM
    J Biol Chem; 2001 Jun; 276(22):19027-32. PubMed ID: 11259424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane type-1 matrix metalloproteinase promotes human melanoma invasion and growth.
    Iida J; Wilhelmson KL; Price MA; Wilson CM; Pei D; Furcht LT; McCarthy JB
    J Invest Dermatol; 2004 Jan; 122(1):167-76. PubMed ID: 14962105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MT1-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells.
    Pulyaeva H; Bueno J; Polette M; Birembaut P; Sato H; Seiki M; Thompson EW
    Clin Exp Metastasis; 1997 Mar; 15(2):111-20. PubMed ID: 9062387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.
    Jo Y; Yeon J; Kim HJ; Lee ST
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP.
    Bernardo MM; Fridman R
    Biochem J; 2003 Sep; 374(Pt 3):739-45. PubMed ID: 12755684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MT1-MMP modulates melanoma cell dissemination and metastasis through activation of MMP2 and RAC1.
    Shaverdashvili K; Wong P; Ma J; Zhang K; Osman I; Bedogni B
    Pigment Cell Melanoma Res; 2014 Mar; 27(2):287-96. PubMed ID: 24387669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competitive disruption of the tumor-promoting function of membrane type 1 matrix metalloproteinase/matrix metalloproteinase-14 in vivo.
    Nonaka T; Nishibashi K; Itoh Y; Yana I; Seiki M
    Mol Cancer Ther; 2005 Aug; 4(8):1157-66. PubMed ID: 16093431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis.
    Deryugina EI; Soroceanu L; Strongin AY
    Cancer Res; 2002 Jan; 62(2):580-8. PubMed ID: 11809713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-kappa B-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells.
    Philip S; Bulbule A; Kundu GC
    J Biol Chem; 2001 Nov; 276(48):44926-35. PubMed ID: 11564733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of membrane-type-1 matrix metalloproteinase activity by its cytoplasmic domain.
    Lehti K; Valtanen H; Wickström SA; Lohi J; Keski-Oja J
    J Biol Chem; 2000 May; 275(20):15006-13. PubMed ID: 10748199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma.
    Seftor RE; Seftor EA; Koshikawa N; Meltzer PS; Gardner LM; Bilban M; Stetler-Stevenson WG; Quaranta V; Hendrix MJ
    Cancer Res; 2001 Sep; 61(17):6322-7. PubMed ID: 11522618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane-type 1 matrix metalloproteinase enhances lymph node metastasis of gastric cancer.
    Yonemura Y; Endo Y; Takino T; Sakamoto K; Bandou E; Kinoshita K; Fushida S; Miwa K; Sugiyama K; Sasaki T
    Clin Exp Metastasis; 2000; 18(4):321-7. PubMed ID: 11448063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.